Skip to main content
Premium Trial:

Request an Annual Quote

Bioinformatics Company Qlucore Raises $840K

NEW YORK (GenomeWeb News) – Swedish bioinformatics firm Qlucore today announced it has raised $840,000 to support the expansion of its sales and marketing operations as well as development work.

The investment came from GLD Invest and will go toward the creation of a US sales office and the expansion of its product development team in Sweden. Qlucore's lead product is the Qlucore Omics Explorer for analyzing gene expression, microarray, real-time PCR, and DNA methylation data as well as other kinds of scientific data.

Qlucore has customers in 17 countries, including large pharmaceutical firms and universities. It announced a distribution deal with Filgen in March covering Qlucore Omics Explorer in Japan.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.